OMB APPROVAL
  UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 		OMB Number: 3235-0058
  Expires: August 31, 2015
  Estimated average burden hours per response. 2.50

 

  FORM 12b-25 SEC FILE NUMBER
   000-53540
     
    CUSIP NUMBER
  NOTIFICATION OF LATE FILING  01551X 108

 

(Check one): [X] Form 10-K           [_] Form 20-F           [_] Form 11-K           [_] Form 10-Q        [_] Form 10-D
[_] Form N-SAR       [_] Form N-CSR
   
  For Period Ended: March 31, 2017
[_] Transition Report on Form 10-K
[_] Transition Report on Form 20-F
[_] Transition Report on Form 11-K
[_] Transition Report on Form 10-Q
[_] Transition Report on Form N-SAR
 
For the Transition Period Ended: ____________________

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

PART I — REGISTRANT INFORMATION

 

Algae Dynamics Corp.
Full Name of Registrant
 
 
Former Name if Applicable
 
4120 Ridgeway Drive, Unit 37
Address of Principal Executive Office (Street and Number)
 
Mississauga, ON L5L 5S9 Ontario
City, State and Zip Code

 

 

 

     
   

 

PART II — RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

      (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
         
  [X]   (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D,or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
         
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III — NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

Over the past several months the Registrant has undertaken a shift in its business strategy and it is completing a significant revision to its business discussion which is not yet complete.

 

PART IV — OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

  Joseph P. Galda, Esq.   215   815-1534
  (Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
   
  Yes  [X]     NO  [  ]
   
   
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
   
  Yes  [  ]     NO  [X]
   
  If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

     
   

 

ALGAE DYNAMICS CORP.

(Name of Registrant as Specified in Charter)

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:   June 30, 2017   By: /s/ Ross Eastley, Chief Financial Officer

 

     
   

Canaquest Medical (PK) (USOTC:CANQF)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Canaquest Medical (PK).
Canaquest Medical (PK) (USOTC:CANQF)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Canaquest Medical (PK).